Hill-Rom

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Hill-Rom sits in the top decile of US sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count).

18 total trials none currently recruiting 15 completed top decile by trial count

Hill-Rom: 18 sponsored US clinical trials, none currently recruiting.

Hill-Rom sponsors 18 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 15 completed. The most-studied condition in this pipeline is Pulmonary Complications, with 1 trials.

Top-decile sponsor footprint

Hill-Rom ranks in the top decile of sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 48/100

15 of 18 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Indexed trials (enrollment closed)

18 total, page 1 of 1

TERMINATED NA

A Pilot Study to Evaluate the Use of the Vest® System for Treatment of Bronchiectasis Patients in the Home Setting

NCT04017312
COMPLETED NA

Incontinence Management System ICU Field Evaluation

NCT03628833
COMPLETED NA

AFT/CLP-LAL RCT Stage 3 or 4 Pressure Injuries

NCT03463434
COMPLETED NA

MN4000 for Treatment of CF and MND Patients in the Home Setting

NCT03797677
TERMINATED

Evaluation of an Incontinence Product

NCT03023072
COMPLETED NA

MetaNeb® Chest X-ray Study

NCT02871258
COMPLETED NA

Evaluation of The MetaNeb® System to Reduce Postoperative Pulmonary Complications

NCT02627742
COMPLETED

Holy Name Progressive Mobility in the ICU

NCT02533622
COMPLETED

Air Fluidized Therapy (AFT) in Patients With Suspected Deep Tissue Injury (sDTI)

NCT01292980
COMPLETED

Early Progressive Mobility in the CVICU: Assessing Current Status

NCT01295541
COMPLETED NA

P400 for Stage II-IV Pressure Ulcers in Home and Extended Care

NCT01139879
COMPLETED NA

Pilot Study of Incidence and Change in Existing Pressure Ulcers: TC500 Bed Compared With Standard Beds

NCT00771238
COMPLETED NA

Study Assessing High-Frequency Chest Wall Oscillation (HFCWO) in Preventing Pulmonary Exacerbations

NCT00739310
COMPLETED NA

HFCWO in Hospitalized Asthmatic Children

NCT00722020
COMPLETED NA

Evaluation of High-Frequency Chest Wall Oscillation

NCT00717873
COMPLETED

A Pilot Study of the Envision® Surface

NCT00405834
COMPLETED

Envision® Surface Evaluation

NCT00405795
TERMINATED NA

Safety Study to Evaluate Intracranial Pressure During High Frequency Chest Wall Oscillation

NCT00279097

Therapeutic Areas

Pulmonary Complications 1
Atelectasis 1
Fecal Incontinence 1
Pressure Ulcer 1
Urinary Incontinence 1

How the Hill-Rom archive is shaped

18 indexed studies, none listed as recruiting (0% open); 15 completed (83%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Pulmonary Complications (1 trial), 4 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Hill-Rom: archived-pipeline peers nationwide

Peers matched on 18 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Hill-Rom sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05101520 0%10%20%30%40% Total trials Recruiting share Hill-RomADC Therapeutics S.A.Akros PharmaAO Clinical Investigation and Publishing DocumentationAO Innovation Translation Center10xBio22nd Century Group23andMe3-C Institute for Social Development
Hill-Rom sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Hill-Rom sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 18 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Hill-Rom page

18 registered trials is a research-attention snapshot, not an endorsement of Hill-Rom or any single study.

  • None of Hill-Rom's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Pulmonary Complications is the condition Hill-Rom studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Pulmonary Complications trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Hill-Rom pipeline card: 18 registered trials from official public datasets.Report a data error.